Using Global Patient Data to Design Smarter Clinical Trials
Large-scale patient databases and AI analytics can accelerate site activation, strengthen recruitment, and improve trial design.
Gen Li, PhD, MBA, president of Phesi, discussed the company's analysis on global inequity in breast cancer development in a recent video interview with Applied Clinical Trials.
He highlighted the geographic concentration of breast cancer trial leaders in the US and China, with a positive outlook on global diversity.
Operational Barriers and Opportunities
Li attributed operational barriers in lower-income countries to traditional business models, emphasizing the need for a more patient-centric approach using AI and machine learning.
- Identifying local leaders to address the lack of local KOLs in underserved areas
- Redistributing trial workloads and improving recruitment using AI to identify and activate new sites
Author's summary: AI analytics can improve clinical trial design.